Nthabiseng Bapela: Interpreting INR in Patients on Warfarin – A Practical Clinical Framework
Nthabiseng Bapela, Healthcare Intelligence System Specialist at MerithRX, shared a post on LinkedIn:
“Interpreting INR in patients on warfarin: a practical clinical framework
The International Normalized Ratio (INR) is central to monitoring warfarin therapy, but it should never be interpreted in isolation. An INR result only becomes meaningful when considered alongside the patient’s indication for anticoagulation, target range, bleeding risk, and current clinical context.
A structured approach to INR interpretation
1. Confirm the indication for warfarin
Start by identifying why the patient is anticoagulated. Common indications include:
- Atrial fibrillation
- DVT and PE
- Mechanical prosthetic heart valves
This matters because the target INR depends on the indication and, in valve patients, the type of valve.
2. Compare the result with the patient’s target INR
In broad terms:
- INR below target indicates subtherapeutic anticoagulation, with an increased thromboembolic risk
- INR within target indicates therapeutic anticoagulation
- INR above target indicates supratherapeutic anticoagulation, with an increased bleeding risk
3. Interpret the INR in clinical context
An abnormal INR should prompt review of factors that commonly affect warfarin control:
- Missed or extra doses
- Drug interactions (e.g. antibiotics, azole antifungals, amiodarone, NSAIDs, antiplatelets, herbal products)
- Dietary vitamin K changes
- Alcohol intake
- Acute illness, diarrhoea, vomiting, reduced oral intake, or liver dysfunction
- Trend in previous INR results
4. Assess the patient, not just the laboratory value
Always consider whether there is evidence of:
- Bleeding: melaena, haematuria, epistaxis, bruising, heavy menstrual bleeding, haematemesis, or unexplained anaemia
- Thromboembolism if the INR is low: stroke symptoms, chest pain, dyspnoea, or limb swelling depending on the indication
Why this matters
Warfarin remains a high-risk medicine because both under-anticoagulation and over-anticoagulation can cause harm. A low INR may leave the patient inadequately protected from stroke, recurrent VTE, or valve thrombosis, while a high INR increases the risk of major bleeding.
Pharmacist practice point
INR is not simply a number to classify as low or high. It is a marker of anticoagulation intensity that must be interpreted in relation to the patient’s indication, target range, medicines, comorbidities, and clinical presentation.
For pharmacists, reviewing INR means asking not only ‘Is this result out of range?’ but also ‘Why is it out of range, and is the patient safe right now?'”
Stay updated with Hemostasis Today.
-
Jul 6, 2026, 19:20Hamza Mohamed: Key Highlights from the 2026 AHA/ACC Multisociety Guideline on Acute PE
-
Jul 6, 2026, 18:58Mostafa Faisal: High PNH Type II Neutrophil Proportions Are Associated With Thrombosis
-
Jul 6, 2026, 17:57When Hematocrit Exceeds 70 Percent: Challenges in Peripheral Blood Smear Evaluation and CBC Analysis – Seema Dawood
-
Jul 6, 2026, 17:382026 ACC/AHA Multisociety Dyslipidemia Guideline: Key Updates for Vascular Specialists – Batool Abuhalimeh
-
Jul 6, 2026, 17:27Nicolas Gendron: Should Carbon Footprint Influence Therapeutic Decisions?
-
Jul 6, 2026, 17:15Sanchit Sharma։ Continuous Anticoagulation in PVT with Varices
-
Jul 6, 2026, 14:48Muhammad Salman Babar: Why Vitamin B12 Treatment Can Lower Potassium
-
Jul 6, 2026, 14:30Abhijit Majumder: Deep Vein Thrombosis – A Silent but Preventable Medical Emergency
-
Jul 6, 2026, 14:26Why Factor XI Deficiency Deserves Greater Awareness – Haemophilia Foundation Australia